KZR
Kezar Life Sciences Inc
Halal Rating :
Last Price
$6.16
Last updated:
Market Cap
-
7D Change
-2.22%
1 Year Change
638.17%
Company Overview
Industries
Exchange
Next Earnings Date
Kezar Life Sciences Inc is a clinical-stage biotechnology company that discovers and develops novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The company's lead product candidate, KZR-616, is being developed for the treatment of several autoimmune diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Kezar Life Sciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.